managed dsip ii equity strategy Why DEI in Private Matters More Than Ever Managed Volatility and Long-Short Equity
Managed Volatility and Long Short Equity Paths Acadian Due Diligence in Private Equity: Safeguarding Deals A surprising deal from Vertex Pharmaceuticals adds to Big Pharma's acquisitive streak as Crinetics folds into the cystic fibrosis drugmaker. Meanwhile, IPOs and venture capital raises trend upward, but mostly for derisked Reimagining the 60 40 Portfolio with Private Equity Secondaries Evaluating Options for Income Diversification in Private Debt CAIS Investment Management David Vaughan Investments
Pay in 4 interest-free payments of $6.74 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9


